Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3908_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Foreword
- •Foreword
- •Preface
- •Acknowledgments
- •About the Book
- •Contents
- •Contributors
- •References
- •2.3.1 Component Therapy
- •2.3.1.1 Tranexamic Acid
- •2.3.1.3 Factor Concentrate-Based Resuscitation Strategies
- •2.3.1.4 Factor VIIa
- •Conclusion
- •References
- •3.1 Blunt Cerebrovascular Injuries
- •3.4 Medical Treatment
- •3.5 Endovascular Treatment
- •3.6 Penetrating Cervical Vascular Injuries
- •References
- •4.1 Introduction
- •4.2 Initial Evaluation
- •4.3 Line Placement Considerations
- •4.5 Embolization Agents
- •4.6 Gelfoam
- •4.7 Particles
- •4.8 Metallic Coils
- •4.9 Amplatzer Vascular Plugs
- •4.10 Liver Endovascular Embolization
- •4.11 Spleen Endovascular Embolization
- •4.12 Kidney Endovascular Embolization
- •4.13 Pelvic Endovascular Embolization
- •4.14 Endovascular Stent Grafts
- •4.15 Axillosubclavian Injuries
- •4.16 Thoracic Endovascular Aortic Repair
- •Conclusion
- •Expert’s Comments by Yoram Kluger
- •References
- •5.1 Introduction
- •5.2 Endovascular Damage Control
- •5.3 Lower Extremity Vascular Injuries
- •5.3.1 Common Femoral Artery
- •5.3.2 Profunda Femoris
- •5.3.3 Superficial Femoral Artery
- •5.3.4 Popliteal Artery
- •5.3.5 Infrapopliteal Arteries
- •5.4 Venous Injuries
- •5.6 Upper Extremity Vascular Injuries
- •5.6.1 Axillo-subclavian Arteries
- •5.7 Postoperative Care
- •References
- •6.1 Introduction
- •6.2 History
- •6.3 Indications
- •6.4 Procedure
- •6.4.1 Arterial Access
- •6.4.3 Sheath Placement
- •6.4.5 Management While Occluded
- •6.4.6 Balloon Deflation
- •6.5 Current Research
- •Conclusion
- •Expert’s Comments by Catherine Arvieux
- •References
- •7: Partial REBOA
- •7.1 Introduction
- •7.2 Physiology
- •7.6 Feasibility
- •7.7 Future Directions
- •Conclusion
- •References
- •8.1 Introduction
- •8.2 Traumatic Brain Injury
- •8.2.1 Epidemiology
- •8.2.2 Normal Brain Physiology
- •8.2.3 Pathophysiology After Traumatic Brain Injury
- •8.4 Future Directions
- •Expert’s Comments by Edoardo Picetti
- •References
- •9.1 Introduction
- •9.4 Mitigation Strategies
- •9.4.2 Balloon Occlusion Time
- •9.4.3 Partial REBOA
- •9.4.4 Pharmacologic Interventions
- •9.4.5 Nitric Oxide Inhibitors
- •9.4.6 Valproic Acid
- •9.4.7 Adenosine
- •9.4.8 Heme Oxygenase
- •9.4.9 Statins
- •9.4.10 Hypothermia
- •Conclusion
- •References
- •10.1 Introduction
- •10.3.2 Clinical Evidence
- •References
- •10.2 Nontraumatic Cardiac Arrest
- •10.2.1 Epidemiology
- •10.2.2 Physiology
- •10.3.1 Preclinical Studies
- •10.3.1.1 Intermittent Occlusion
- •10.3.1.2 Continuous Occlusion
- •10.3.1.3 Selective Aortic Arch Perfusion
- •11.1 Introduction
- •11.3 Uterine Blood Supply
- •11.5 First Trimester
- •11.5.1 Ectopic Pregnancy
- •11.5.2 Molar Pregnancy
- •11.6.1 Placental Abruption
- •11.6.2 Trauma
- •11.6.3 Postpartum Hemorrhage
- •11.6.4 Placenta Accreta Spectrum
- •11.8 Massive Transfusion Protocols
- •11.9 Adjunctive Medications
- •11.9.1 Tranexamic Acid
- •11.9.2 Lyophilized Fibrinogen Concentrate
- •11.9.3 Prothrombin Complex Concentrates (PCCs)
- •11.9.4 Activated Recombinant Factor VII
- •11.10 Endovascular Balloon Occlusion
- •References
- •12.1 Introduction
- •12.2 Prehospital EVTM
- •12.3 Austere EVTM
- •Conclusion
- •Expert’s Comments by Miklosh Bala
- •References
- •13.1 Background
- •13.2 Categorizing Bleeding Severity
- •13.3.1 Emergency IR (EIR)
- •13.5 Trauma IR (TIR)
- •13.5.1 Overview
- •13.5.2 Preadmission
- •13.5.4 Trauma Imaging
- •13.5.5 Patient Selection
- •13.6.1 Overview
- •13.6.2 Procedure
- •13.6.2.3 Embolic Agents
- •13.7 Future Trends
- •13.7.1 Hybrid ER Room
- •13.8 Hybrid Trauma Specialist
- •Conclusion
- •References
- •14.1 Introduction
- •14.3 Communication
- •14.4 Crew Resource Management
- •14.5 REBOA Before or After Anesthesia?
- •14.6 Nonarterial Circulatory Access
- •14.9 Analgesia
- •14.10 Hemostatic Resuscitation
- •14.11 Afterload Reduction
- •14.12 Monitoring
- •14.13 Electrolyte Management
- •14.14 Balloon Deflation
- •Conclusion
- •References
- •15.2 VV ECMO
- •15.3 VV ECMO Circuit Management
- •15.3.1 VV ECMO Cannulation Strategies
- •15.3.2 Monitoring Targets
- •15.4 VV ECMO Patient Management
- •15.4.1 Anticoagulation Range
- •15.4.2 Ventilator Management
- •15.4.3 Sedation Strategies
- •15.4.4 Peri-procedural Management
- •15.5 VA ECMO
- •Conclusions
- •References
- •16.1 Introduction
- •16.4 Access-Related Complications
- •16.6 Fluid Resuscitation
- •16.8 Extracorporeal Membrane Oxygenation
- •16.9 Coagulation
- •16.11 Renal Function
- •Conclusions
- •Expert’s Comments by Andrew Kirkpatrick
- •References
- •17.1 Access Site Complications
- •17.1.1 Hematoma
- •17.1.2 Pseudoaneurysm
- •17.1.3 Acquired Arteriovenous Fistula
- •17.2 Intervention Complications
- •17.2.1 Dissection
- •17.2.2 Thrombosis/Embolization
- •17.2.3 Rupture
- •17.3 Post-procedure Complications
- •17.3.1 Infection
- •17.3.2 Contrast-Induced Nephropathy
- •17.3.3 Contrast Media Allergy
- •Conclusion
- •References
- •18.6.1 Simulators
- •18.6.2 Porcine Models
- •18.6.3 Cadaver
- •18.6.4 Cath-Lab Training
- •18.7 Summary
- •References

93
setting [58]. In the future, Partial-REBOA aims to decrease distal ischemia by
allowing titrated, controlled, low-volume ow distal to aortic occlusion while
maintaining physiologic carotid ow [60].
References
1. Kauvar DS, Lefering R, Wade CE.Impact of hemorrhage on trauma outcome: an overview
of epidemiology, clinical presentations, and therapeutic considerations. J Trauma. 2006;60(6
Suppl):S3–11.
2. Eastridge BJ, Hardin M, Cantrell J, Oetjen-Gerdes L, Zubko T, Mallak C, etal. Died of wounds
on the battleeld: causation and implications for improving combat casualty care. J Trauma.
2011;71(1 Suppl):S4–8.
3. Hermreck AS.The history of cardiopulmonary resuscitation. Am J Surg. 1988;156(6):430–6.
4. Burlew CC, Moore EE.Emergency department thoracotomy. In: Mattox KME, Feliciano D,
editors. Trauma. 7th ed. NewYork, NY: McGraw-Hill Companies, Inc; 2013.
5. Rhee PM, Acosta J, Bridgeman A, Wang D, Jordan M, Rich N. Survival after emergency
department thoracotomy: review of published data from the past 25 years. J Am Coll Surg.
2000;190(3):288–98.
6. Millikan JS, Moore EE.Outcome of resuscitative thoracotomy and descending aortic occlu-
sion performed in the operating room. J Trauma. 1984;24(5):387–92.
7. Ledgerwood AM, Kazmers M, Lucas CE.The role of thoracic aortic occlusion for massive
hemoperitoneum. J Trauma. 1976;16(08):610–5.
8. DuBose J, Fabian T, Bee T, Moore LJ, Holcomb JB, Brenner M, etal. Contemporary utiliza-
tion of resuscitative thoracotomy: results from the AAST aortic occlusion for resuscitation in
trauma and acute care surgery (AORTA) multicenter registry. Shock. 2018;50(4):414–20.
9. Moore LJ, Brenner M, Kozar RA, Pasley J, Wade CE, Baraniuk MS, etal. Implementation of
resuscitative endovascular balloon occlusion of the aorta as an alternative to resuscitative thora-
cotomy for noncompressible truncal hemorrhage. J Trauma Acute Care Surg. 2015;79(4):523–
30; discussion 30–2.
10. Assar AN, Zarins CK. Endovascular proximal control of ruptured abdominal aortic aneu-
rysms: the internal aortic clamp. J Cardiovasc Surg (Torino). 2009;50(3):381–5.
11. White JM, Cannon JW, Stannard A, Markov NP, Spencer JR, Rasmussen TE.Endovascular
balloon occlusion of the aorta is superior to resuscitative thoracotomy with aortic clamping in
a porcine model of hemorrhagic shock. Surgery. 2011;150(3):400–9.
12. Bif WL, Fox CJ, Moore EE.The role of REBOA in the control of exsanguinating torso hem-
orrhage. J Trauma Acute Care Surg. 2015;78(5):1054–8.
13. Brenner M, Teeter W, Hoehn M, Pasley J, Hu P, Yang S, etal. Use of resuscitative endovascular
balloon occlusion of the aorta for proximal aortic control in patients with severe hemorrhage
and arrest. JAMA Surg. 2018;153:130.
14. Lallemand MS, Moe DM, McClellan JM, Smith JP, Daab L, Marko S, et al. Resuscitative
endovascular balloon occlusion of the aorta for major abdominal venous injury in a porcine
hemorrhagic shock model. J Trauma Acute Care Surg. 2017;83(2):230–6.
15. Hughes CW.Use of an intra-aortic balloon catheter tamponade for controlling intra-abdominal
hemorrhage in man. Surgery. 1954;36(1):65–8.
16. Low RB, Longmore W, Rubinstein R, Flores L, Wolvek S.Preliminary report on the use of the
Percluder occluding aortic balloon in human beings. Ann Emerg Med. 1986;15(12):1466–9.
17. Gupta BK, Khaneja SC, Flores L, Eastlick L, Longmore W, Shaftan GW.The role of intra-
aortic balloon occlusion in penetrating abdominal trauma. J Trauma. 1989;29(6):861–5.
18. Greenberg RK, Srivastava SD, Ouriel K, Waldman D, Ivancev K, Illig KA, etal. An endolu-
minal method of hemorrhage control and repair of ruptured abdominal aortic aneurysms. J
Endovasc Ther. 2000;7(1):1–7.
6 Principles ofREBOA

94
19. Malina M, Veith F, Ivancev K, Sonesson B.Balloon occlusion of the aorta during endovascular
repair of ruptured abdominal aortic aneurysm. J Endovasc Ther. 2005;12(5):556–9.
20. Paull JD, Smith J, Williams L, Davison G, Devine T, Holt M. Balloon occlusion of the
abdominal aorta during caesarean hysterectomy for placenta percreta. Anaesth Intensive Care.
1995;23(6):731–4.
21. Matsuoka S, Uchiyama K, Shima H, Ohishi S, Nojiri Y, Ogata H. Temporary percutaneous
aortic balloon occlusion to enhance uid resuscitation prior to denitive embolization of post-
traumatic liver hemorrhage. Cardiovasc Intervent Radiol. 2001;24(4):274–6.
22. Bell-Thomas SM, Penketh RJ, Lord RH, Davies NJ, Collis R. Emergency use of a trans-
femoral aortic occlusion catheter to control massive haemorrhage at caesarean hysterectomy.
BJOG. 2003;110(12):1120–2.
23. Tang X, Guo W, Yang R, Tang S, Dong S.Use of aortic balloon occlusion to decrease blood
loss during sacral tumor resection. J Bone Joint Surg Am. 2010;92(8):1747–53.
24. Sovik E, Stokkeland P, Storm BS, Asheim P, Bolas O. The use of aortic occlusion balloon
catheter without uoroscopy for life-threatening post-partum haemorrhage. Acta Anaesthesiol
Scand. 2012;56(3):388–93.
25. Martinelli T, Thony F, Declety P, Sengel C, Broux C, Tonetti J, et al. Intra-aortic balloon
occlusion to salvage patients with life-threatening hemorrhagic shocks from pelvic fractures. J
Trauma. 2010;68(4):942–8.
26. Schwartz DA, Medina M, Cotton BA, Rahbar E, Wade CE, Cohen AM, etal. Are we deliver-
ing two standards of care for pelvic trauma? Availability of angioembolization after hours
and on weekends increases time to therapeutic intervention. J Trauma Acute Care Surg.
2014;76(1):134–9.
27. Brenner ML, Moore LJ, DuBose JJ, Tyson GH, McNutt MK, Albarado RP, etal. A clinical
series of resuscitative endovascular balloon occlusion of the aorta for hemorrhage control and
resuscitation. J Trauma Acute Care Surg. 2013;75(3):506–11.
28. Brenner M, Hoehn M, Pasley J, Dubose J, Stein D, Scalea T. Basic endovascular skills for
trauma course: bridging the gap between endovascular techniques and the acute care surgeon.
J Trauma Acute Care Surg. 2014;77(2):286–91.
29. Romagnoli AN, Teeter W, Wasicek P, Gamble WB, Hu P, Stein D, etal. No wire? No problem:
resuscitative endovascular balloon occlusion of the aorta can be performed effectively and
more rapidly with a wire-free device. J Trauma Acute Care Surg. 2018;85(5):894–8.
30. Brenner M, Inaba K, Aiol A, DuBose J, Fabian T, Bee T, etal. Resuscitative endovascular bal-
loon occlusion of the aorta and resuscitative thoracotomy in select patients with hemorrhagic
shock: early results from the American Association for the Surgery of Trauma Aortic Occlusion
in resuscitation for trauma and acute care surgery registry. J Am Coll Surg. 2018;226:730.
31. Romagnoli A, Teeter W, Pasley J, Hu P, Hoehn M, Stein D, etal. Time to aortic occlusion: it’s
all about access. J Trauma Acute Care Surg. 2017;83(6):1161–4.
32. DuBose JJ, Scalea TM, Brenner M, Skiada D, Inaba K, Cannon J, etal. The AAST prospective
aortic occlusion for resuscitation in trauma and acute care surgery (AORTA) registry: data on
contemporary utilization and outcomes of aortic occlusion and resuscitative balloon occlusion
of the aorta (REBOA). J Trauma Acute Care Surg. 2016;81:409.
33. Stannard A, Eliason JL, Rasmussen TE.Resuscitative endovascular balloon occlusion of the
aorta (REBOA) as an adjunct for hemorrhagic shock. J Trauma. 2011;71(6):1869–72.
34. Burlew CC, Moore EE, Moore FA, Coimbra R, McIntyre RC Jr, Davis JW, et al. Western
Trauma Association critical decisions in trauma: resuscitative thoracotomy. J Trauma Acute
Care Surg. 2012;73(6):1359–63.
35. Cannon J, et al. JTS Clinical Practice Guideline on Resuscitative Endovascular Balloon
Occlusion of the Aorta (REBOA) for hemorrhagic shock. Mil Med. 2018;183(Suppl
2):55. Available from: http://jts.amedd.army.mil/assets/docs/cpgs/JTS_Clinical_Practice_
Guidelines_(CPGs)/REBOA_for_Hemorrhagic_Shock_06_Jul_2017_ID38.pdf.
36. Teeter W, Romagnoli A, Wasicek P, Hu P, Yang S, Stein D, etal. Resuscitative endovascular
balloon occlusion of the aorta improves cardiac compression fraction versus resuscitative tho-
racotomy in patients in traumatic arrest. Ann Emerg Med. 2018;72:354.
A. Romagnoli and M. Brenner

95
37. Bradley M, Bonds BW, Chang L, Yang S, Hu P, Li H, Brenner M, Scalea T, Stein D.Open
chest cardiac massage offers no benet over closed chest compressions in patients with trau-
matic cardiac arrest. J Trauma Acute Care Surg. 2016;81:849.
38. Gamberini E, Coccolini F, Tamagnini B, Martino C, Albarello V, Benni M, etal. Resuscitative
endovascular balloon occlusion of the aorta in trauma: a systematic review of the literature.
World J Emerg Surg. 2017;12:42.
39. Tsurukiri J, Akamine I, Sato T, Sakurai M, Okumura E, Moriya M, etal. Resuscitative endo-
vascular balloon occlusion of the aorta for uncontrolled haemorrahgic shock as an adjunct
to haemostatic procedures in the acute care setting. Scand J Trauma Resusc Emerg Med.
2016;24:13.
40. Stensaeth KH, Sovik E, Haig IN, Skomedal E, Jorgensen A. Fluoroscopy-free resuscitative
endovascular balloon occlusion of the aorta (REBOA) for controlling life threatening postpar-
tum hemorrhage. PLoS One. 2017;12(3):e0174520.
41. Okada A, Nakamoto O, Komori M, Arimoto H, Rinka H, Nakamura H.Resuscitative endovas-
cular balloon occlusion of the aorta as an adjunct for hemorrhagic shock due to uterine rupture:
a case report. Clinical Case Rep. 2017;5(10):1565–8.
42. Zhang Y, Guo W, Tang X, Yang R, Yan T, Dong S, etal. Can aortic balloon occlusion reduce
blood loss during resection of sacral tumors that extend into the lower lumber spine? Clin
Orthop Relat Res. 2018;476(3):490–8.
43. Rosenthal MD, Raza A, Markle S, Croft CA, Mohr AM, Smith RS.The novel use of resuscita-
tive endovascular balloon occlusion of the aorta to explore a retroperitoneal hematoma in a
hemodynamically unstable patient. Am Surg. 2017;83(4):337–40.
44. Kalish J, Eslami M, Gillespie D, Schermerhorn M, Rybin D, Doros G, etal. Routine use of
ultrasound guidance in femoral arterial access for peripheral vascular intervention decreases
groin hematoma rates. J Vasc Surg. 2015;61(5):1231–8.
45. Inagaki E, Farber A, Siracuse JJ, Mell MW, Rybin DV, Doros G, etal. Routine use of ultra-
sound guidance in femoral arterial access for peripheral vascular intervention decreases groin
hematoma rates in high-volume surgeons. Ann Vasc Surg. 2018;51:1.
46. Meyer DE, Mont MT, Harvin JA, Kao LS, Wade CE, Moore LJ. Catheter distances and bal-
loon ination volumes for the ER-REBOA catheter: a prospective analysis. In: 70th Annual
Meeting of Southwestern Surgical Congress Quick Shot presentation; 2018.
47. Davidson AJ, Russo RM, Reva VA, Brenner ML, Moore LJ, Ball C, etal. The pitfalls of resus-
citative endovascular balloon occlusion of the aorta: risk factors and mitigation strategies. J
Trauma Acute Care Surg. 2018;84(1):192–202.
48. Beldowicz BC, Galante JM.Resuscitative endovascular balloon occlusion of the aorta in inter-
hospital transfers. J Endovasc Resuscit Trauma Manag. 2018;2(1):44.
49. Teeter WA, Matsumoto J, Idoguchi K, Kon Y, Orita T, Funabiki T, et al. Smaller introducer
sheaths for REBOA may be associated with fewer complications. J Trauma Acute Care Surg.
2016;81:1039.
50. Brenner M, More L, Teeter W, Hu P, Yang S, Wasicek P, Pasley J, Taylor J, Harvin J, Stein
D, Scalea T. Exclusive clinical experience with a lower prole device for resuscitative endo-
vascular balloon occlusion of the aorta (REBOA). In: 70th Annual Meeting of Southwestern
Surgical Congress Podium presentation; 2018.
51. Brenner M, Bulger EM, Perina DG, Henry S, Kang CS, Rotondo MF, etal. Joint statement
from the American College of Surgeons Committee on Trauma (ACS COT) and the American
College of Emergency Physicians (ACEP) regarding the clinical use of Resuscitative
Endovascular Balloon Occlusion of the Aorta (REBOA). Trauma Surg Acute Care Open.
2018;3(1):e000154.
52. Saito N, Matsumoto H, Yagi T, Hara Y, Hayashida K, Motomura T, etal. Evaluation of the
safety and feasibility of resuscitative endovascular balloon occlusion of the aorta. J Trauma
Acute Care Surg. 2015;78(5):897–903; discussion 4.
53. Okada Y, Narumiya H, Ishi W, Ryoji I.Lower limb ischemia caused by resuscitative balloon
occlusion of aorta. Surg Case Rep. 2016;2(1):130.
6 Principles ofREBOA

96
54. Uchino H, Tamura N, Echigoya R, Ikegami T, Fukuoka T. “REBOA”- is it really safe? A case
with massive intracranial hemorrhage possibly due to endovascular balloon occlusion of the
aorta (REBOA). Am J Case Rep. 2016;17:810–3.
55. Johnson MA, Williams TK, Ferencz SE, Davidson AJ, Russo RM, O’Brien WT Sr, etal. The
effect of resuscitative endovascular balloon occlusion of the aorta, partial aortic occlusion and
aggressive blood transfusion on traumatic brain injury in a swine multiple injuries model. J
Trauma Acute Care Surg. 2017;83(1):61–70.
56. Teeter W, Romagnoli A, Glaser J, Fisher AD, Pasley J, Scheele B, et al. Resuscitative
endovascular balloon occlusion of the aorta: pushing care forward. J Spec Oper Med.
2017;17(1):17–21.
57. Pasley JD, Teeter WA, Gamble WB, Wasick P, Romagnoli AN, Pasley AM, etal. Bringing
resuscitative endovascular balloon occlusion of the aorta (REBOA) closer to the point of
injury. J Spec Oper Med. 2018;18(1):33–6.
58. Manley JD, Mitchell BJ, DuBose JJ, Rasmussen TE.A modern case series of resuscitative
endovascular balloon occlusion of the aorta (REBOA) in an out-of-hospital, combat casualty
care setting. J Spec Oper Med. 2017;17(1):1–8.
59. Lyon RF, Northern DM. REBOA by a non-surgeon as an adjunct during MASCAL: a case
report. Am J Emerg Med. 2018;36:1121.e5.
60. Russo RM, Williams TK, Grayson JK, Lamb CM, Cannon JW, Clement NF, etal. Extending
the golden hour: partial resuscitative endovascular balloon occlusion of the aorta (P-REBOA)
in a highly lethal swine liver injury model. J Trauma Acute Care Surg. 2016;80:372–8.
61. DuBose JJ. How I do it: partial resuscitative endovascular balloon occlusion of the aorta
(P-REBOA). J Trauma Acute Care Surg. 2017;83(1):197–9.
62. Morrison JJ, Ross JD, Houston R, Watson JD, Sokol KK, Rasmussen TE.Use of resuscitative
endovascular balloon occlusion of the aorta in a highly lethal model of noncompressible torso
hemorrhage. Shock. 2014;41(2):130–7.
63. Manzano-Nunez R, Orlas CP, Herrera-Escobar JP, etal. A meta-analysis of the incidence of
complications associated with groin access after the use of resuscitative endovascular balloon
occlusion of the aorta in trauma patients. J Trauma Acute Care Surg. 2018;85:626.
64. Pieper A, Thony F, Brun J, etal. Resuscitative endovascular balloon occlusion of the aorta for
pelvic blunt trauma and life-threatening hemorrhage: a 20-year experience in a Level I trauma
center. J Trauma Acute Care Surg. 2018;84(3):449–53.
A. Romagnoli and M. Brenner

97
© Springer Nature Switzerland AG 2020
T. Hörer et al. (eds.), Endovascular Resuscitation and Trauma Management,
Hot Topics in Acute Care Surgery and Trauma,
https://doi.org/10.1007/978-3-030-25341-7_7
A. J. Davidson
Department of Surgery, University of California Davis Medical Center,
Sacramento, CA, USA
e-mail: ajdavidson@ucdavis.edu
T. K. Williams (
*)
Vascular and Endovascular Surgery, Wake Forest Baptist Health, Winston-Salem, NC, USA
7
Partial REBOA
AndersJ.Davidson andTimothyK.Williams
7.1 Introduction
Resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as
a feasible technique for modern hemorrhage control and trauma resuscitation [1, 2].
REBOA results in decreased bleeding below the level of complete occlusion and
augmentation of blood pressure and blood ow to the heart, lungs, and brain [3].
While initially advocated for trauma patients in extremis as an alternative to emer-
gency thoracotomy, the indications for REBOA have continued to expand [4]. Its
use has been described as a prophylactic hemorrhage control adjunct in major elec-
tive surgery, for the management of postpartum hemorrhage, and in nontraumatic
cardiac arrest [5–10].
Despite its increasing utilization and broadening applications, REBOA carries
several negative physiologic consequences primarily related to the profound distal
ischemia created by complete aortic occlusion. Additionally, REBOA can pro-
duce severe supraphysiologic proximal hypertension and cardiac afterload, which
may have detrimental effects [11, 12]. One proposed alternative to complete aortic
occlusion is a technique of partial REBOA (P-REBOA) [13]. The application of
partial aortic occlusion allows a limited amount of blood ow beyond the occlu-
sion balloon. This technique maintains the benets of increased perfusion created
above the level of occlusion, while simultaneously allowing some blood ow to
areas distal to the level of occlusion. The purpose of P-REBOA is to minimize
distal ischemia and limit proximal hypertension, while simultaneously limiting
downstream bleeding. This may serve to extend the duration of intervention,

98
allowing prolonged application in scenarios where hemorrhage control will be
delayed beyond the ischemia threshold of complete REBOA (Figs.7.1, 7.2, 7.3,
7.4, 7.5, and 7.6, Table7.1).
Complete
Partial
None
abc
Fig. 7.1 (a–c) P-REBOA is partial aortic balloon occlusion and can occur anywhere between 0%
and 100% occlusion. This makes P-REBOA dynamic and able to respond to physiologic changes,
but makes comparison of studies difcult
Intravascular
volume
Cardiac
output
Regional
ischemia
Circulating
catecholamines
Vasoconstriction
Blood
pressure
Amount
of aortic
occlusion
Aortic diameter
Aortic
flow
Fig. 7.2 Determinants of aortic ow. Reliably predicting aortic ow at a given degree of occlusion
is difcult given complex interactions between physiologic, mechanical, and metabolic factors
A. J. Davidson and T. K. Williams

99
Fig. 7.3 Establishing arterial access is key for P-REBOA.Distal pressure can be transduced through
the femoral sheath through which a REBOA catheter is placed, or though the contralateral femoral
artery. Proximal pressure can be transduced through a radial arterial line or directly from more mod-
ern occlusion catheters such as the ER-REBOA™. The black arrow denotes arterial sheath with
REBOA (note integrated arterial pressure port). The white arrow denotes contralateral femoral access
30 cc “course
adjustment” syringe
Distal arterial pressure
monitoring via sheath
5 cc “fine adjustment”
syringe
Fig. 7.4 Our preferred
setup for REBOA.Note
“course ination” syringe,
“ne adjustment” syringe,
and distal arterial pressure
monitoring through arterial
sheath. This example
utilizes an ER-REBOA™
catheter, which can also
transduce proximal arterial
pressure
7 Partial REBOA

100
Complete
Proximal aortic pressure
150
100
MAP (mmHg)
60
50
0
030
Time (min)
60 90
Partial
Control
Fig. 7.5 Effects of REBOA, P-REBOA, and no occlusion on proximal blood pressure during
intervention in a translational animal model of trauma. Note supraphysiologic pressures created by
REBOA with more physiologic blood pressures in the P-REBOA group. The vertical red line at
90min indicates balloon deation. The horizontal red line indicates mean arterial pressure of 60
Metabolic burden over time
Complete
Partial
Control
BSL
2
4
6
Lactate (mmol/L)
8
10
12
0153045
Time (min)
60 75 90 95 100 105
Fig. 7.6 Effects of REBOA, P-REBOA, and no occlusion on circulating lactic acid over time. The
red line at 90min indicates balloon deation
A. J. Davidson and T. K. Williams

101
This chapter will discuss the technique of P-REBOA including the physiology of
partial aortic occlusion, translational and early clinical data of P-REBOA, as well as
future considerations for continued renement of the technique.
7.2 Physiology
7.2.1 The Effects ofComplete Aortic Occlusion
Occlusion of the descending aorta is associated with a complex hemodynamic
response with several intended and unintended physiologic consequences.
It creates a relative arterial hypertension proximal to the level of occlusion with
a redistribution of blood ow in order to preserve perfusion to vital proximal organs
[14]. Although some scant collateral arterial blood ow remains, this is insufcient
to maintain organ viability over prolonged periods [15]. Therefore, aortic occlusion
creates an “on the clock” phenomenon, with progressive ischemia as a function of
the duration of occlusion [16]. Ultimately, this can result in irreversible ischemia
once a critical time threshold has been passed [17]. Additionally, once aortic blood
ow is restored, these distal tissue beds experience a reperfusion injury with a wash-
out of ischemic metabolites such as potassium and lactic acid. This ischemia-
reperfusion injury is quite dramatic and is the primary reason that aortic occlusion
is a time-sensitive modality [18]. Notably, patients experience worse outcomes the
longer aortic occlusion is maintained due to this phenomenon [19].
The primary intended consequence of aortic occlusion is a near instantaneous
increase in blood pressure proximal to the level of occlusion with a resultant
increase in blood ow to organs cranial to the level of occlusion. In the shock
state, this has the ability to promote and maintain perfusion to critical organs such
as the heart, lungs, and brain [20]. The development of arterial hypertension is the
most consistent and dramatic nding that occurs during aortic occlusion. This
increase in blood ow has the desired effect of maintenance of perfusion; how-
ever, often this dramatic increase in pressure can create an additional burden on
the heart and may exacerbate injuries such as traumatic brain injury or pulmonary
contusions [21, 22].
Table 7.1 Comparison of REBOA and P-REBOA
REBOA
P-REBOA
Proximal blood pressure Supraphysiologic More physiologic
Distal ischemia Near complete Relative ischemia
Metabolite washout Immediate with return of distal blood
ow
More protracted
Degree of aortic occlusion Static: Only complete Dynamic 0–99%
Potential for ongoing
bleeding
Minimal Considerable
Ease of use Simpler: Single provider Difcult: multiple
providers
Tolerable duration of use Shorter Longer
7 Partial REBOA

102
The two primary physiologic limitations of aortic occlusion are ischemia and
reperfusion. This pathologic condition is characterized by an initial restriction of
blood supply followed by subsequent restoration of perfusion and oxygenation. The
ischemic period is associated with impaired endothelial cell barrier function with a
concomitant increase in blood vessel permeability and leakage. In the short term,
this causes a cellular transition to anaerobic metabolism in the affected tissues with
inhibition of key enzymes that require oxygen as a cofactor. This is associated with
alterations to transcription and gene expression. As the duration of ischemia is
increased, activation of cell death (apoptosis) occurs. This in turn causes a release
of proteases, lysosomes, and key intracellular electrolytes (i.e., potassium) into the
extracellular compartment. These ischemic metabolites will continue to collect as
the duration of ischemia increases. Eventually, an organ reaches an ischemic thresh-
old of irreversibility beyond which recovery cannot occur [23]. Reperfusion then
reintroduces blood ow into the area. This creates an abrupt “washout” of these
ischemic metabolites to the systemic circulation. If the duration of ischemia is short,
this may be of limited physiologic consequence. However, if the duration is longer,
there may be severe consequences such as cardiac arrest or multiorgan failure.
Resistance to ischemic injury is dependent on the organ type and its metabolic
requirements for oxygen (i.e., skeletal muscle is more resistant and kidneys are less
resistant) [24].
7.2.2 The Effects ofPartial REBOA
The physiologic rationale for P-REBOA is to decrease distal ischemia by allowing
limited blood ow beyond the level of occlusion, while simultaneously reducing
proximal hypertension and cardiac afterload. This limited downstream blood ow
created by P-REBOA generates a “relative” ischemia as opposed to “complete”
ischemia created by REBOA, which serves to extend the duration of intervention
and limit the reperfusion injury that occurs at the time of full balloon deation.
Furthermore, P-REBOA may mitigate the “washout” of ischemic metabolites expe-
rienced during reperfusion by continuously clearing some metabolites through con-
tinued low volume distal ow. Additionally, P-REBOA may lessen the potentially
detrimental effects of proximal arterial hypertension and increased afterload associ-
ated with complete aortic occlusion. In theory, this will decrease the strain on the
heart, and may reduce the potential for pulmonary or cerebral edema.
In the context of uncontrolled injury, P-REBOA does create the potential for
ongoing bleeding by perpetuating blood ow to injured vascular beds. This is inher-
ently unpredictable and inuenced by factors such as the extent and location of
injury, tamponade and thrombus formation at the injury site, and overall coagulation
status. It is conceivable that hemorrhage may ensue, particularly from injuries
involving large blood vessels such as the aorta and its primary branches. However,
this bleeding may occur at tolerable levels that can be met by ongoing resuscitation
efforts. This concept is supported by the notion of permissive hypotension after
traumatic injury [25]. The theory is that low arterial blood pressures may support
A. J. Davidson and T. K. Williams
Соседние файлы в папке Библиотека им академика М.И. Перельмана
